Noninvasive prenatal screening leverages DNA from placental cells found in a pregnant person's bloodstream to detect random genetic conditions, such as Down syndrome. The immune system adapts during pregnancy, lowering its response to protect the developing fetus, allowing these foreign cells to persist. Interestingly, while cell-free DNA clears quickly post-birth, intact cells can remain in the mother's body for years.
